{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:36:53Z","timestamp":1773797813189,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T00:00:00Z","timestamp":1285632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s11934-010-0142-4","type":"journal-article","created":{"date-parts":[[2010,9,27]],"date-time":"2010-09-27T06:52:25Z","timestamp":1285570345000},"page":"405-413","source":"Crossref","is-referenced-by-count":6,"title":["Recent Advances in the Medical and Surgical Treatment of Priapism"],"prefix":"10.1007","volume":"11","author":[{"given":"Adam","family":"Shrewsberry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad W. M.","family":"Ritenour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"142_CR1","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0090-4295(01)00941-4","volume":"57","author":"IA Eland","year":"2001","unstructured":"Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ: Incidence of priapism in the general population. Urology 2001, 57:970\u2013972.","journal-title":"Urology"},{"key":"142_CR2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","volume":"7","author":"GA Broderick","year":"2010","unstructured":"\u2022\u2022 Broderick GA, Kadioglu A, Bivalacqua TJ, et al.: Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010, 7:476\u2013500. This is the most recent review and consensus article that presents evidence-based guidelines for the treatment of priapism.","journal-title":"J Sex Med"},{"key":"142_CR3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","volume":"170","author":"DK Montague","year":"2003","unstructured":"Montague DK, Jarow J, Broderick GA, et al.: American Urological Association guideline on the management of priapism. J Urol 2003, 170:1318\u20131324.","journal-title":"J Urol"},{"issue":"Suppl 5","key":"142_CR4","first-page":"S39","volume":"13","author":"R Berger","year":"2001","unstructured":"Berger R, Billups K, Brock G, et al.: Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impot Res 2001, 13(Suppl 5):S39\u2013S43.","journal-title":"Int J Impot Res"},{"key":"142_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(01)66575-3","volume":"155","author":"N Muruve","year":"1996","unstructured":"Muruve N, Hosking DH: Intracorporeal phenylephrine in the treatment of priapism. J Urol 1996, 155:141\u2013143.","journal-title":"J Urol"},{"key":"142_CR6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.ijir.3901231","volume":"17","author":"A Muneer","year":"2005","unstructured":"Muneer A, Cellek S, Dogan A, et al.: Investigation of cavernosal smooth muscle dysfunction in low flow priapism using an in vitro model. Int J Impot Res 2005, 17:10\u201318.","journal-title":"Int J Impot Res"},{"key":"142_CR7","doi-asserted-by":"crossref","unstructured":"Munarriz R, Wen CC, McAuley I, et al.: Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med 2006, 3:918\u2013922. (Published erratum appears in J Sex Med 2006, 3:938.)","DOI":"10.1111\/j.1743-6109.2005.00140.x"},{"key":"142_CR8","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1743-6109.2008.00862.x","volume":"5","author":"A Muneer","year":"2008","unstructured":"Muneer A, Minhas S, Freeman A, et al.: Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism. J Sex Med 2008, 5:2152\u20132159.","journal-title":"J Sex Med"},{"key":"142_CR9","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-5347(05)66371-9","volume":"165","author":"DJ Ralph","year":"2001","unstructured":"Ralph DJ, Pescatori ES, Brindley GS, Pryor JP: Intracavernosal phenylephrine for recurrent priapism: self-administration by drug delivery implant. J Urol 2001, 165:1632.","journal-title":"J Urol"},{"key":"142_CR10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1590\/S1677-55382004000200007","volume":"30","author":"M McDonald","year":"2004","unstructured":"McDonald M, Santucci RA: Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol. Int Braz J Urol 2004, 30:121\u2013122.","journal-title":"Int Braz J Urol"},{"key":"142_CR11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0090-4295(96)00027-1","volume":"47","author":"R Virag","year":"1996","unstructured":"Virag R, Bachir D, Lee K, Galacteros F: Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine. Urology 1996, 47:777\u2013781.","journal-title":"Urology"},{"key":"142_CR12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","volume":"118","author":"I Okpala","year":"2002","unstructured":"Okpala I, Westerdale N, Jegede T, Cheung B: Etilefrine for the prevention of priapism in adult sickle cell disease. Br J Haematol 2002, 118:918\u2013921.","journal-title":"Br J Haematol"},{"key":"142_CR13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue TF: Erectile dysfunction. N Engl J Med 2000, 342:1802\u20131813.","journal-title":"N Engl J Med"},{"key":"142_CR14","first-page":"S15","volume":"170","author":"G Lin","year":"2003","unstructured":"Lin G, Xin ZC, Lue TF, Lin CS: Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. J Urol 2003, 170:S15\u2013S19.","journal-title":"J Urol"},{"key":"142_CR15","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","volume":"102","author":"HC Champion","year":"2005","unstructured":"Champion HC, Bivalacqua TJ, Takimoto E, et al.: Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci U S A 2005, 102:1661\u20131666.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"142_CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2164\/jandrol.107.003483","volume":"29","author":"AL Burnett","year":"2008","unstructured":"\u2022 Burnett AL: Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health. J Androl 2008, 29:3\u201314. This review discusses the role of PDE5 as it contributes to various erectile disorders such as hypogonadism-associated erectile dysfunction, recurrent ischemic priapism, penile vasculopathy, and penile fibrosis. Existing and emerging therapeutic strategies regarding PDE5 are reviewed.","journal-title":"J Androl"},{"key":"142_CR17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.ju.0000173006.47623.2c","volume":"174","author":"B Musicki","year":"2005","unstructured":"Musicki B, Champion HC, Becker RE, et al.: In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect. J Urol 2005, 174:1493\u20131496.","journal-title":"J Urol"},{"key":"142_CR18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","volume":"3","author":"AL Burnett","year":"2006","unstructured":"Burnett AL, Bivalacqua TJ, Champion HC, Musicki B: Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism. J Sex Med 2006, 3:1077\u20131084.","journal-title":"J Sex Med"},{"key":"142_CR19","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.urology.2009.04.071","volume":"74","author":"D Rachid-Filho","year":"2009","unstructured":"Rachid-Filho D, Cavalcanti AG, Favorito LA, et al.: Treatment of recurrent priapism in sickle cell anemia with finasteride: a new approach. Urology 2009, 74:1054\u20131057.","journal-title":"Urology"},{"key":"142_CR20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0091-3057(88)90245-6","volume":"31","author":"D Bitran","year":"1988","unstructured":"Bitran D, Miller SA, McQuade DB, et al.: Inhibition of sexual reflexes by lumbosacral injection of a GABAB agonist in the male rat. Pharmacol Biochem Behav 1988, 31:657\u2013666.","journal-title":"Pharmacol Biochem Behav"},{"key":"142_CR21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0003-9993(98)90061-2","volume":"79","author":"P Denys","year":"1998","unstructured":"Denys P, Mane M, Azouvi P, et al.: Side effects of chronic intrathecal baclofen on erection and ejaculation in patients with spinal cord lesions. Arch Phys Med Rehabil 1998, 79:494\u2013496.","journal-title":"Arch Phys Med Rehabil"},{"key":"142_CR22","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.1097\/BRS.0b013e31818d04ff","volume":"34","author":"G D\u2019Aleo","year":"2009","unstructured":"D\u2019Aleo G, Rifici C, Kofler M, et al.: Favorable response to intrathecal, but not oral, baclofen of priapism in a patient with spinal cord injury. Spine (Phila PA 1976) 2009, 34:E127\u2013E129.","journal-title":"Spine (Phila PA 1976)"},{"key":"142_CR23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.juro.2009.06.040","volume":"182","author":"MR Abern","year":"2009","unstructured":"\u2022 Abern MR, Levine LA: Ketoconazole and prednisone to prevent recurrent ischemic priapism. J Urol 2009, 182:1401\u20131406. This study suggests that ketoconazole and prednisone therapy with dose titration and testosterone monitoring may be effective at preventing priapism recurrence without creating castrate levels of testosterone.","journal-title":"J Urol"},{"key":"142_CR24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.ijir.3901180","volume":"16","author":"S Priyadarshi","year":"2004","unstructured":"Priyadarshi S: Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res 2004, 16:424\u2013426.","journal-title":"Int J Impot Res"},{"key":"142_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0090-4295(93)90338-B","volume":"42","author":"FC Lowe","year":"1993","unstructured":"Lowe FC, Jarow JP: Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology 1993, 42:51\u201353.","journal-title":"Urology"},{"key":"142_CR26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08880010802435146","volume":"26","author":"A Gupta","year":"2009","unstructured":"Gupta A, Seth T, Gupta A: Successful use of terbutaline in persistent priapism in a 12-year-old boy with chronic myeloid leukemia. Pediatr Hematol Oncol 2009, 26:70\u201373.","journal-title":"Pediatr Hematol Oncol"},{"key":"142_CR27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0090-4295(01)01492-3","volume":"59","author":"P Dahm","year":"2002","unstructured":"Dahm P, Rao DS, Donatucci CF: Antiandrogens in the treatment of priapism. Urology 2002, 59:138.","journal-title":"Urology"},{"key":"142_CR28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.10069","volume":"69","author":"AD Gbado\u00e9","year":"2002","unstructured":"Gbado\u00e9 AD, Assimadi JK, S\u00e9gb\u00e9na YA: Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia. Am J Hematol 2002, 69:297\u2013298.","journal-title":"Am J Hematol"},{"key":"142_CR29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1743-6109.2005.00106.x","volume":"2","author":"R Shamloul","year":"2005","unstructured":"Shamloul R, el Nashaar A: Idiopathic stuttering priapism treated successfully with low-dose ethinyl estradiol: a single case report. J Sex Med 2005, 2:732\u2013734.","journal-title":"J Sex Med"},{"key":"142_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","volume":"77","author":"ST Saad","year":"2004","unstructured":"Saad ST, Lajolo C, Gilli S, et al.: Follow-up of sickle cell disease patients with priapism treated by hydroxyurea. Am J Hematol 2004, 77:45\u201349.","journal-title":"Am J Hematol"},{"key":"142_CR31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.ijir.3901165","volume":"16","author":"P Perimenis","year":"2004","unstructured":"Perimenis P, Athanasopoulos A, Papathanasopoulos P, Barbalias G: Gabapentin in the management of the recurrent, refractory, idiopathic priapism. Int J Impot Res 2004, 16:84\u201385.","journal-title":"Int J Impot Res"},{"key":"142_CR32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0022-5347(05)66012-0","volume":"166","author":"S Rutchik","year":"2001","unstructured":"Rutchik S, Sorbera T, Rayford RW, Sullivan J: Successful treatment of recalcitrant priapism using intracorporeal injection of tissue plasminogen activator. J Urol 2001, 166:628.","journal-title":"J Urol"},{"key":"142_CR33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/B:UROL.0000025617.97048.ae","volume":"35","author":"J H\u00fcbler","year":"2003","unstructured":"H\u00fcbler J, Sz\u00e1nt\u00f3 A, K\u00f6nyves K: Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol 2003, 35:519\u2013521.","journal-title":"Int Urol Nephrol"},{"key":"142_CR34","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/00005392-199805000-00033","volume":"159","author":"S Gupta","year":"1998","unstructured":"Gupta S, Salimpour P, Saenz de Tejada I, et al.: A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium\/potassium adenosine triphosphate activity. J Urol 1998, 159:1529\u20131536.","journal-title":"J Urol"},{"key":"142_CR35","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1743-6109.2008.01163.x","volume":"6","author":"AL Burnett","year":"2009","unstructured":"Burnett AL, Santiago CS 3rd: Resolution of recurrent ischemic priapism after celiac plexus block: case report evidence for its neurogenic origin? J Sex Med 2009, 6:886\u2013889.","journal-title":"J Sex Med"},{"key":"142_CR36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0090-4295(76)90498-2","volume":"8","author":"CC Winter","year":"1976","unstructured":"Winter CC: Cure of idiopathic priapism: new procedure for creating fistula between glans penis and corpora cavernosa. Urology 1976, 8:389\u2013391.","journal-title":"Urology"},{"key":"142_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/02844317409084400","volume":"8","author":"J Ebbehoj","year":"1974","unstructured":"Ebbehoj J: A new operation for priapism. Scand J Plast Reconstr Surg 1974, 8:241\u2013242.","journal-title":"Scand J Plast Reconstr Surg"},{"key":"142_CR38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-5347(17)54971-X","volume":"125","author":"CJ Ercole","year":"1981","unstructured":"Ercole CJ, Pontes JE, Pierce JM Jr: Changing surgical concepts in the treatment of priapism. J Urol 1981, 125:210\u2013211.","journal-title":"J Urol"},{"key":"142_CR39","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.ju.0000081291.37860.a5","volume":"170","author":"RG Nixon","year":"2003","unstructured":"Nixon RG, O\u2019Connor JL, Milam DF: Efficacy of shunt surgery for refractory low flow priapism: a report on the incidence of failed detumescence and erectile dysfunction. J Urol 2003, 170:883\u2013886.","journal-title":"J Urol"},{"key":"142_CR40","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.juro.2008.12.021","volume":"181","author":"WO Brant","year":"2009","unstructured":"\u2022 Brant WO, Garcia MM, Bella AJ, et al.: T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism. J Urol 2009, 181:1699\u20131705. This article describes a new surgical distal shunt technique that allows recanalization of corporal circulation. This technique can be performed at the bedside under local anesthesia.","journal-title":"J Urol"},{"key":"142_CR41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1743-6109.2008.01176.x","volume":"6","author":"AL Burnett","year":"2009","unstructured":"\u2022 Burnett AL, Pierorazio PM: Corporal \u201csnake\u201d maneuver: corporoglanular shunt surgical modification for ischemic priapism. J Sex Med 2009, 6:1171\u20131176. This article describes a modified Al-Ghorab corporoglanular shunt surgery that appears to offer an advantageous management approach to resolving ischemic priapism.","journal-title":"J Sex Med"},{"key":"142_CR42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.eururo.2008.10.009","volume":"56","author":"M Kilinic","year":"2009","unstructured":"Kilinic M: Temporary cavernosal-cephalic vein shunt in low-flow priapism treatment. Eur Urol 2009, 56:559\u2013562.","journal-title":"Eur Urol"},{"key":"142_CR43","first-page":"5","volume":"32","author":"R Quackels","year":"1964","unstructured":"Quackels R: Cure of a patient suffering from priapism by caverno-spongiosa anasatomosis [in French]. Acta Urol Belg 1964, 32:5\u201313.","journal-title":"Acta Urol Belg"},{"key":"142_CR44","first-page":"509","volume":"1","author":"JT Grayhack","year":"1964","unstructured":"Grayhack JT, McCullough W, O\u2019Connor V Jr, Trippel O: Venous bypass to control priapism. Invest Urol 1964, 1:509\u2013513.","journal-title":"Invest Urol"},{"key":"142_CR45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.urology.2008.10.025","volume":"73","author":"RK Chiou","year":"2009","unstructured":"Chiou RK, Aggarwal H, Mues AC, et al.: Clinical experience and sexual function outcome of patients with priapism treated with penile cavernosal-dorsal vein shunt using saphenous vein graft. Urology 2009, 73:556\u2013561.","journal-title":"Urology"},{"issue":"Suppl 5","key":"142_CR46","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1038\/sj.ijir.3901078","volume":"15","author":"DJ Bochinski","year":"2003","unstructured":"Bochinski DJ, Deng DY, Lue TF: The treatment of priapism\u2014when and how? Int J Impot Res 2003, 15(Suppl 5):S86\u2013S90.","journal-title":"Int J Impot Res"},{"key":"142_CR47","first-page":"175","volume":"7","author":"RV Kulmala","year":"1995","unstructured":"Kulmala RV, Lehtonen TA, Lindholm TS, Tammela TL: Permanent open shunt as a reason for impotence or reduced potency after surgical treatment of priapism in 26 patients. Int J Impot Res 1995, 7:175\u2013180.","journal-title":"Int J Impot Res"},{"key":"142_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13645700802649193","volume":"18","author":"H Kojima","year":"2009","unstructured":"\u2022 Kojima H, Tanigawa N, Kariya S, et al.: High-flow priapism undergoing arterial embolization: review of literature following American Urological Association guideline on the management of priapism. Minim Invasive Ther Allied Technol 2009, 18:1\u20135. This article is a review of all reports published after the introduction of the American Urological Association guideline on the management of priapism to compare temporary and permanent occlusive agents in the treatment of high-flow priapism in terms of symptom improvement and onset of erectile dysfunction.","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"142_CR49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0090-4295(96)00176-8","volume":"48","author":"DS Sandock","year":"1996","unstructured":"Sandock DS, Seftel AD, Herbener TE, et al.: Perineal abscess after embolization for high-flow priapism. Urology 1996, 48:308\u2013311.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0142-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-010-0142-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-010-0142-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T02:58:24Z","timestamp":1559703504000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-010-0142-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,28]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1007\/s11934-010-0142-4","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,28]]}}}